Literature DB >> 22213057

Comparison of radioguided occult lesion localization (ROLL) and wire localization for non-palpable breast cancers: a meta-analysis.

Muhammad S Sajid1, Umesh Parampalli, Zishan Haider, Ricardo Bonomi.   

Abstract

Four randomized trials encompassing 449 patients of non-palpable breast cancer undergoing with radio-guided occult lesion localization (ROLL) or wire guided localization (WGL). In the fixed effects model, accurate localization, peri-procedural complications, and reoperation rate were comparable between two techniques. Risk of having positive resection margins following WGL was higher. Duration of localization and surgical excision was shorter for ROLL. Volume and weight of the excised occult breast lesion was similar in WGL and ROLL groups.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22213057     DOI： 10.1002/jso.23016

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  22 in total

1.  iROLL: does 3-D radioguided occult lesion localization improve surgical management in early-stage breast cancer?

Authors:  Christina Bluemel; Andreas Cramer; Christoph Grossmann; Georg W Kajdi; Uwe Malzahn; Nora Lamp; Heinz-Jakob Langen; Jan Schmid; Andreas K Buck; Hanns-Jörg Grimminger; Ken Herrmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-09       Impact factor: 9.236

2.  Ultrasound-guided preoperative localization of breast lesions: a good choice.

Authors:  Giorgio Carlino; Pierluigi Rinaldi; Michela Giuliani; Rossella Rella; Enida Bufi; Federico Padovano; Chiara Ciardi; Maurizio Romani; Paolo Belli; Riccardo Manfredi
Journal:  J Ultrasound       Date:  2018-10-26

Review 3.  Impalpable breast lesion localisation, a logistical challenge: results of the UK iBRA-NET national practice questionnaire.

Authors:  Santosh K Somasundaram; Shelley Potter; Suzanne Elgammal; Anthony J Maxwell; Amtul S Sami; Sue K Down; Rajiv V Dave; James Harvey
Journal:  Breast Cancer Res Treat       Date:  2020-09-10       Impact factor: 4.872

Review 4.  Current status of ultrasound-guided surgery in the treatment of breast cancer.

Authors:  José H Volders; Max H Haloua; Nicole Ma Krekel; Sybren Meijer; Petrousjka M van den Tol
Journal:  World J Clin Oncol       Date:  2016-02-10

5.  Accurate resection of nonpalpable, ultrasonography undetectable breast cancer tumor by preoperative indocyanine green injection using stereotactic mammography: A case report.

Authors:  Atsushi Muraoka; Masahiko Kobayashi
Journal:  Ann Med Surg (Lond)       Date:  2022-06-07

6.  A low cost training phantom model for radio-guided localization techniques in occult breast lesions.

Authors:  Fatih Aydogan; Melissa Anne Mallory; Mustafa Tukenmez; Yasuaki Sagara; Erkan Ozturk; Yavuz Ince; Varol Celik; Tamer Akca; Mehra Golshan
Journal:  J Surg Oncol       Date:  2015-08-06       Impact factor: 3.454

Review 7.  Localization techniques for guided surgical excision of non-palpable breast lesions.

Authors:  Benjamin K Y Chan; Jill A Wiseberg-Firtell; Ramesh H S Jois; Katrin Jensen; Riccardo A Audisio
Journal:  Cochrane Database Syst Rev       Date:  2015-12-31

8.  Second Look Ultrasonography-Guided Breast Biopsy with Magnetic Resonance Imaging Confirmation by Intralesional Contrast Injection.

Authors:  Yasemin Kayadibi; Fahrettin Kılıç; Ravza Yılmaz; Mehmet Velidedeoğlu; Tülin Öztürk; Deniz Esin Tekcan; Emel Ure Esmerer; Fatih Aydoğan; Mehmet Halit Yılmaz
Journal:  Eur J Breast Health       Date:  2020-12-24

9.  Preoperative Localization of Breast MRI Lesions: MRI-guided Marker Placement With Radioactive Seed Localization as an Alternative to MRI-guided Wire Localization.

Authors:  Nicole Saphier; Jessica Kondraciuk; Elizabeth Morris; Blanca Bernard-Davila; Victoria Mango
Journal:  J Breast Imaging       Date:  2020-04-23

10.  Optimizing surgical margins in breast conservation.

Authors:  Preya Ananthakrishnan; Fatih Levent Balci; Joseph P Crowe
Journal:  Int J Surg Oncol       Date:  2012-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.